Prevalence and etiology of epilepsy in a Norwegian county—A population based study

Abstract

SUMMARYObjective: Epilepsy represents a substantial personal and social burden worldwide. When addressing the multifaceted issues of epilepsy care, updated epidemiologic studies using recent guidelines are essential. The aim of this study was to find the prevalence and causes of epilepsy in a representative Norwegian county, implementing the new guidelines and terminology suggested by the International League Against Epilepsy (ILAE). Methods: Included in the study were all patients from Buskerud County in Norway with a diagnosis of epilepsy at Drammen Hospital and the National Center for Epilepsy at Oslo University Hospital. The study period was 1999-2014. Patients with active epilepsy were identified through a systematic review of medical records, containing information about case history, electroencephalography (EEG), cerebral magnetic resonance imaging (MRI), genetic tests, blood samples, treatment, and other investigations. Epilepsies were classified according to the revised terminology suggested by the ILAE in 2010. Results: In a population of 272,228 inhabitants, 1,771 persons had active epilepsy. Point prevalence on January 1, 2014 was 0.65%. Of the subjects registered with a diagnostic code of epilepsy, 20% did not fulfill the ILAE criteria of the diagnosis. Epilepsy etiology was structural-metabolic in 43%, genetic/presumed genetic in 20%, and unknown in 32%. Due to lack of information, etiology could not be determined in 4%. Significance: Epilepsy is a common disorder, affecting 0.65% of the subjects in this cohort. Every fifth subject registered with a diagnosis of epilepsy was misdiagnosed. In those with a reliable epilepsy diagnosis, every third patient had an unknown etiology. Future advances in genetic research will probably lead to an increased identification of genetic and hopefully treatable causes of epilepsy.

Comorbidity and Childhood Epilepsy: A Nationwide Registry Study

“…However, previous studies of epilepsy in Norway, based on data from single counties, have found positive predictive values of 80% 69 and 74% 70 for registered diagnoses of epilepsy, indicating a relatively high quality of the data. Another study found a high quality of autism diagnoses in the NPR, with a positive predictive value of 94% (95% CI, 79%-99%).…”

Antiepileptic drug withdrawal in juvenile myoclonic epilepsy

“…25 Drammen Hospital serves the inhabitants of Buskerud county and four neighboring municipalities, that is, a population of 477 000 people, or 9.1% of Norway's total population. All medical records containing an International Classification of Diseases, 10th Revision (ICD-10) code of epilepsy (G40) were reviewed.…”

EFHC1 variants in juvenile myoclonic epilepsy: reanalysis according to NHGRI and ACMG guidelines for assigning disease causality

“…Population prevalence for Hispanics was determined by a door-to-door study performed in rural Bolivia in 1999. 32 Prevalence among Caucasians was determined by a study of the Norwegian National registry in 2015, 33 and East Asian prevalence by a study of the regional registry of patients older than 15 years in Hong Kong, China. 34 Another estimate of Southeast Asian prevalence was produced via a random cluster survey of Cambodian villages.…”